Objective:
To provide an overview of active clinical trials in age-related macular degeneration (AMD), diabetic macular edema (DME), retinal vein occlusion (RVO), and uveitis.
Approach:
- Wet AMD Trials: Listing of completed trials including NT-101 and OCS-01 eye drops.
- Dry AMD Trials: Overview of new trials assessing dietary interventions and various treatments for geographic atrophy.
Key Findings:
- The trials for NT-101 and OCS-01 eye drops for wet AMD are completed.
- Multiple new studies have been initiated for dry AMD focusing on dietary interventions and pharmacological treatments.
- Trials include various designs such as randomized, double-masked, and multicenter studies.
Limitations:
- The article does not provide detailed results or outcomes from the completed trials.
- Limited information on the methodologies and participant demographics of the studies.
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







